Jinping McCormick
8Patents
4h-index
30Co-inventors
53Inventor score
Filing activity: Apr 18, 1997 → Apr 22, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6403564B1 | Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection | Human Necessities | 55 | Expired |
| US6800434B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 47 | Expired |
| US6277830A | 5'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon | Human Necessities | 46 | Expired |
| USRE43298E1 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | General | 15 | Active |
| US5763600A | Oligosaccharide antibiotics and process for preparation thereof | Chemistry; Metallurgy | 2 | Expired |
| US6673775B2 | Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7595299B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Chemistry; Metallurgy | 0 | Expired |
| US7115578B2 | Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.